Bruker (BRKR) Non-Current Assets (2010 - 2026)
Bruker's (BRKR) quarterly Non-Current Assets came in at $3.8 billion in Q2 2026, down 8.36% on a YoY basis from $4.2 billion in Q2 2025, and down 4.95% quarter-over-quarter from $4.0 billion in Q1 2026.
Analysis
Bruker (BRKR) Non-Current Assets (2010 - 2026) Analysis & Trends
Bruker (BRKR) has reported Non-Current Assets for 17 consecutive years, with $3.8 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non-Current Assets fell 8.36% year-over-year to $3.8 billion; the trailing twelve-month figure through Jun 2026 stood at $16.0 billion (up 1.88% YoY), and the FY2025 full-year result was $4.0 billion, up 7.34% from the prior year.
- Non-Current Assets declined to $3.8 billion in Q2 2026 per BRKR's latest filing, from $4.0 billion in the prior quarter.
- Across five years, Non-Current Assets topped out at $4.2 billion in Q2 2025 and bottomed at $1.3 billion in Q2 2022.
- Historically, Non-Current Assets has averaged $2.8 billion across 5 years, with a median of $3.1 billion in 2024.
- The sharpest annual moves came in 2024 and 2026: Non-Current Assets soared 124.03% in 2024, then declined 8.36% in 2026.
- Over 5 years, Non-Current Assets stood at $1.5 billion in 2022, then surged by 39.18% to $2.1 billion in 2023, then surged by 79.96% to $3.8 billion in 2024, then increased by 7.34% to $4.0 billion in 2025, then slipped by 4.99% to $3.8 billion in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $3.8 billion, $4.0 billion, and $4.0 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 223.99 Bn | 219.93 Bn | 8.34 Bn | 89.81 Bn |
| 2 | Danaher | 141.56 Bn | 137.22 Bn | 3.61 Bn | 78.99 Bn |
| 3 | Agilent Technologies | 40.36 Bn | 38.60 Bn | 1.04 Bn | 9.27 Bn |
| 4 | Illumina | 30.41 Bn | 29.24 Bn | 770.00 Mn | 3.82 Bn |
| 5 | Revvity | 13.50 Bn | 12.48 Bn | 416.87 Mn | 9.75 Bn |
| 6 | Bio-Techne | 11.25 Bn | 10.98 Bn | 211.39 Mn | 1.84 Bn |
| 7 | Bio-Rad Laboratories | 9.88 Bn | 8.26 Bn | 345.80 Mn | 7.23 Bn |
| 8 | Repligen | 9.29 Bn | 8.28 Bn | 110.04 Mn | 1.75 Bn |
| 9 | 10x Genomics | 8.62 Bn | 8.06 Bn | 112.50 Mn | 355.40 Mn |
| 10 | Bruker | 8.16 Bn | 7.94 Bn | 416.00 Mn | 3.83 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.83 Bn |
| Mar 31, 2026 | 4.03 Bn |
| Dec 31, 2025 | 4.03 Bn |
| Sep 30, 2025 | 4.08 Bn |
| Jun 30, 2025 | 4.18 Bn |
| Mar 31, 2025 | 3.82 Bn |
| Dec 31, 2024 | 3.75 Bn |
| Sep 30, 2024 | 3.92 Bn |
| Jun 30, 2024 | 3.75 Bn |
| Mar 31, 2024 | 2.37 Bn |
| Dec 31, 2023 | 2.09 Bn |
| Sep 30, 2023 | 1.79 Bn |
| Jun 30, 2023 | 1.67 Bn |
| Mar 31, 2023 | 1.63 Bn |
| Dec 31, 2022 | 1.50 Bn |
| Sep 30, 2022 | 1.30 Bn |
| Jun 30, 2022 | 1.30 Bn |
| Mar 31, 2022 | 1.30 Bn |
| Dec 31, 2021 | 1.18 Bn |
| Sep 30, 2021 | 1.14 Bn |